| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |